ELEVANCE HEALTH DL-,01/ US0367521038 /
| 2024-11-07 8:08:16 AM | Chg. +17.20 | Volume | Bid8:11:54 AM | Ask8:11:54 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 398.60EUR | +4.51% | 0 Turnover: 0.00 |
398.50Bid Size: 26 | 400.50Ask Size: 25 | 92.66 bill.EUR | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 25.38 USD | 1.12% |
| EPS Diluted: | 25.22 USD | 1.65% |
| Revenues per Share: | 736.41 USD | 11.67% |
| Book Value per Share: | 169.36 USD | 10.70% |
| Cash Flow per Share: | 34.65 USD | -2.05% |
| Dividend per Share: | 5.92 USD | 15.63% |
| Total | in mill. | |
| Revenues: | 171,340.00 USD | 9.42% |
| Net Income: | 5,987.00 USD | -0.63% |
| Operating Cash Flow: | 8,061.00 USD | - |
| Cash and Cash Equivalents: | 6,526.00 USD | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 16.90 | 18.58 |
| P/S Ratio: | 0.58 | 0.64 |
| P/BV ratio: | 2.53 | 2.78 |
| P/CF Ratio: | 12.38 | 13.61 |
| PEG: | 15.15 | 16.66 |
| Earnings Yield: | 5.92% | 5.38% |
| Dividend Yield: | 1.38% | 1.26% |
| Market Capitalization | ||
| Market Capitalization: | 92.66 bill. EUR | 99.37 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 231.92 mill. | |
Profitability
| Gross Profit Margin: | 17.34% |
| EBIT Margin: | 4.96% |
| Net Profit Margin: | 3.49% |
| Return on Equity: | 15.19% |
| Return on Assets: | 5.50% |
Financial Strength
| Liquidity I / Cash Ratio: | 0.16% |
| Liquidity II / Quick Ratio: | 0.58% |
| Liquidity III / Current Ratio: | 1.44% |
| Debt / Equity Ratio: | 0.64% |
| Dynam. Debt / Equity Ratio: | 862.46% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - USD |
| Revenues / Employee: | - USD |
| Net Income / Employee: | - USD |
| Total Assets / Employee: | - USD |
| * Fiscal Year End: | 2023-12-31 |
| Accounting Standard: | US GAAP |
| Currency: | USD |
